Surface-targeted complement modulation at biomedical interfaces
Trends in Pharmacological Sciences · 2026-08 · 47 (8) · 890-905
DOI: 10.1016/j.tips.2026.06.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-08. Verfasst von Ekaterina Umnyakova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: ekaterina.umnyakova@unibas.ch. Hauptthemen laut MEDLINE: Complement Activation, Complement System Proteins, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Novartis AG, University of Basel.
Abstract (Originalsprache)
The complement system is essential for distinguishing self-tissue from foreign threats; however, complement activation on biomedical surfaces such as implants, transplants, or drug-delivery systems may lead to severe thromboinflammatory complications. Unlike systemic complement inhibitors, surface-targeted strategies remain scarce, despite their potential advantages regarding safety and efficacy. Recent years have seen the emergence of diverse surface-targeting approaches that impair different mechanisms underlying complement-mediated complications. These strategies, ranging from surface coatings to inhibitors targeting complement-tagged surfaces, are progressing from conceptual development to clinical application. In this review, we provide a comprehensive overview of complement-activation mechanisms on biomedical surfaces, highlight ongoing clinical investigations, and discuss a broad spectrum of emerging approaches to prevent adverse complement activation on biomedical interfaces.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: ekaterina.umnyakova@unibas.ch.
- Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Förderung
- Swiss National Science Foundation
- Novartis AG
- University of Basel
- Novartis Foundation
Zitieren
APA
Umnyakova, E., Felsch, J., & Ricklin, D. (2026). Surface-targeted complement modulation at biomedical interfaces. Trends in Pharmacological Sciences, 47(8), 890-905. https://doi.org/10.1016/j.tips.2026.06.005
Vancouver
Umnyakova E, Felsch J, Ricklin D. Surface-targeted complement modulation at biomedical interfaces. Trends in Pharmacological Sciences. 2026;47(8):890-905. doi:10.1016/j.tips.2026.06.005
BibTeX
@article{Umnyakova2026,
author = {Umnyakova, Ekaterina and Felsch, Jannes and Ricklin, Daniel},
title = {Surface-targeted complement modulation at biomedical interfaces},
journal = {Trends in Pharmacological Sciences},
year = {2026},
volume = {47},
number = {8},
pages = {890--905},
doi = {10.1016/j.tips.2026.06.005}
}
EUVIMED